These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 2262893)

  • 1. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    Shannon HE; Peters SC
    J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic modulation of spatial working memory of mice in radial maze performance: retention curve analysis.
    Inagawa K
    Yakubutsu Seishin Kodo; 1993 Aug; 13(4):233-8. PubMed ID: 8237140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex.
    Jones CK; Shannon HE
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1017-23. PubMed ID: 10945854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys.
    Hironaka N; Ando K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):103-8. PubMed ID: 8905798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bidirectional modulation of scopolamine-induced working memory impairments by muscarinic activation of the medial septal area.
    Givens B; Olton DS
    Neurobiol Learn Mem; 1995 May; 63(3):269-76. PubMed ID: 7670840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of muscarinic cholinergic receptor blockade in the rat anterior cingulate and Prelimbic/Infralimbic cortices on spatial working memory.
    Ragozzino ME; Kesner RP
    Neurobiol Learn Mem; 1998 May; 69(3):241-57. PubMed ID: 9707488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves.
    Riekkinen P; Riekkinen M; Fisher A; Ekonsalo T; Sirviö J
    Eur J Pharmacol; 1993 Aug; 240(1):1-7. PubMed ID: 8405117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats.
    Shannon HE; Love PL
    Epilepsy Behav; 2004 Dec; 5(6):857-65. PubMed ID: 15582833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the discriminative stimulus effects of physostigmine in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):241-6. PubMed ID: 2746500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial reference- (not working- or procedural-) memory performance of aged rats in the water maze predicts the magnitude of sulpiride-induced facilitation of acetylcholine release by striatal slices.
    Cassel JC; Lazaris A; Birthelmer A; Jackisch R
    Neurobiol Aging; 2007 Aug; 28(8):1270-85. PubMed ID: 16843572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field.
    Schildein S; Huston JP; Schwarting RK
    Neurobiol Learn Mem; 2000 Jan; 73(1):21-30. PubMed ID: 10686121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-spatial, stimulus-comparison working memory task in rats and disruption by scopolamine.
    Shannon HE; Yang L
    Neuroscience; 2007 Mar; 145(3):955-62. PubMed ID: 17303343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of morphine state-dependent learning by muscarinic cholinergic receptors of the ventral tegmental area.
    Darbandi N; Rezayof A; Zarrindast MR
    Physiol Behav; 2008 Jul; 94(4):604-10. PubMed ID: 18479719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraseptal tacrine-induced disruptions of spatial memory performance.
    Sabolek HR; Bunce JG; Chrobak JJ
    Behav Brain Res; 2005 Mar; 158(1):1-7. PubMed ID: 15680189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat.
    Ray CA; Blin J; Chase TN; Piercey MF
    Neuropharmacology; 1992 Nov; 31(11):1193-9. PubMed ID: 1475026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine.
    Matsuoka N; Aigner TG
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1201-9. PubMed ID: 9067304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats.
    Srikumar BN; Raju TR; Shankaranarayana Rao BS
    Neuroscience; 2006 Dec; 143(3):679-88. PubMed ID: 17008021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.